Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Milatuzumab |
Trade Name | |
Synonyms | IMMU-115|hLL1 |
Drug Descriptions |
Milatuzumab (IMMU-115) is a monocloncal antibody to CD74 that induces apoptosis and targets tumor cells with high CD74 expression, such as B-cells (PMID: 25754579, PMID: 28466956). |
DrugClasses | CD74 Antibody 3 |
CAS Registry Number | 899796-83-9 |
NCIT ID | C66983 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Milatuzumab | Milatuzumab | 0 | 0 |